
Is Harmony Biosciences (HRMY) stock Halal?
As of the September 2026 screening, Harmony Biosciences Holdings, Inc. (HRMY) does not meet the AAOIFI Shariah Standard No. 21 threshold for the interest-bearing investments screen, so the stock is not currently classified as Shariah compliant. It is re-screened every month and can regain compliance if its financial structure changes.
Harmony Biosciences is a biopharmaceutical company engaged in the development and commercialization of innovative therapies. It primarily focuses on addressing unmet needs in the healthcare sector, specifically targeting disorders that impact the central nervous system. As part of its core operations, the company develops treatments that enhance the quality of life for patients with conditions such as narcolepsy and related neurological disorders. For Muslim investors, though, the most pressing question is simpler: is Harmony Biosciences a Halal investment?
Is Harmony Biosciences Shariah compliant?
Technology companies rarely fail AAOIFI screening on what they sell. Software, hardware and digital services are permissible business activities, so for a company like Harmony Biosciences the Shariah question moves to the balance sheet: how much of its market value sits in interest bearing debt, how much of its cash earns Riba in conventional deposits, and whether incidental income from impermissible sources creeps past 5% of revenue. These are exactly the ratios AAOIFI Shariah Standard No. 21 polices, and they move every month with the share price.
Does Harmony Biosciences pass the business activity test?
The activity screen is only part of the picture this month: Harmony Biosciences currently fails the interest-bearing investments screen, so the overall verdict is not compliant regardless of the business itself. The watch item for technology names is incidental: cash returns and platform content can carry impermissible elements, which AAOIFI tolerates only below the thresholds.
Is Harmony Biosciences' income Halal?
Yes, within AAOIFI's tolerance. Harmony Biosciences' income from non-permissible sources stays below 5% of revenue in the September 2026 screening.
Does Harmony Biosciences meet AAOIFI's debt and investment ratio requirements?
Not in full. Interest bearing investments currently exceed the 30% cap, while the other ratio stays within it. One breach is enough to fail the screening; the ratios are reassessed monthly under our Shariah Supervisory Board.
Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.
New to the four screens? Read Why a Halal Stock Screener Matters for Halal Investing



